Floatz logo

Etoposide

Mantle Cell Lymphoma

Ruijin HospitalSmall moleculePhase 4 / ApprovedActive
BBB
75/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
65/ 100
Competitive Position
89/ 100

Competitive context

161 Active assets in the Mantle Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Cis-Diamminedichloroplatinum Ii
National Cancer Institute (NCI)
Phase 4BBB
Busulfanum
City of Hope Medical Center
Phase 2BBB
Cyclosporin A
Fred Hutchinson Cancer Center
Phase 3BBB
Irinotecan
University of Michigan Rogel Cancer Center
Phase 2BBB
Vincristine Sulfate
M.D. Anderson Cancer Center
Phase 2BBB

View all 50 →

Same molecule, other indications

Etoposide is also rated in:

acute megakaryoblastic leukemiaDormant
BBB
Indicative · Phase 3
79 / 100
View asset →
acute monocytic leukemiaDormant
BBB
Indicative · Phase 3
79 / 100
View asset →
acute myeloblastic leukemia with maturationDormant
BBB
Indicative · Phase 3
79 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →